Abstract:Heterogeneity in characteristics from one region (sub-population) to another, commonly observed in complex systems, such as glasses and a collection of cells, is hard to describe theoretically. In the context of cancer, intra-tumor heterogeneity (ITH), characterized by cells with genetic and phenotypic variability that co-exist within a single tumor, is often the cause of ineffective therapy and recurrence of cancer. Multi-region sequencing (M-Seq), obtained by sampling multiple regions of a single tumor, has vividly demonstrated the pervasive nature of ITH, raising the need for a theory that accounts for evolution of tumor heterogeneity. Here, we develop a statistical mechanical theory to quantify ITH, using the Hamming distance, between genetic mutations in distinct regions within a single tumor. An analytic expression for ITH, expressed in terms of cell division probability ($\alpha$) and mutation probability ($p$), is validated using cellular-automaton type simulations. Application of the theory successfully captures ITH extracted from M-seq data in patients with exogenous cancers (melanoma and lung). The theory, based on punctuated evolution at the early stages of the tumor followed by neutral evolution, is accurate provided the spatial variation in the tumor mutation burden is not large. We show that there are substantial variations in ITH in distinct regions of a single solid tumor, which supports the notion that distinct subclones could co-exist. The simulations show that there are substantial variations in the sub-populations, with the ITH increasing as the distance between the regions increases. The analytical and simulation framework developed here could be used in the quantitative analyses of the experimental (M-Seq) data. More broadly, our theory is likely to be useful in analyzing dynamic heterogeneity in complex systems such as super-cooled liquids.

A population genetics perspective on the determinants of intra-tumor heterogeneity

Heterogeneity in Primary Tumors and Corresponding Metastases: Could It Provide Us with Any Hints to Personalize Cancer Therapy?

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

Genetic and non-genetic clonal diversity in cancer evolution

Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

An Evolutionary Genetic Perspective on Cancer Biology

Structure of Intratumor Heterogeneity: Is Cancer Hedging Its Bets?

Epigenomic heterogeneity as a source of tumour evolution

New Insights from the Widening Homogeneity Perspective to Target Intratumor Heterogeneity

Epigenetic Heterogeneity in Cancer

Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches

Clinical implications of intratumor heterogeneity: challenges and opportunities

Cellular Heterogeneity and Molecular Evolution in Cancer

Molecular heterogeneity in breast cancer: State of the science and implications for patient care

On the patterns of genetic intra-tumour heterogeneity before and after treatment

Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics

Investigating intratumour heterogeneity by single-cell sequencing.

Statistical Mechanical theory for spatio-temporal evolution of Intra-tumor heterogeneity in cancers: Analysis of Multiregion sequencing data

Evolving Insights: How DNA Repair Pathways Impact Cancer Evolution

Intratumor Heterogeneity: A New Perspective on Colorectal Cancer Research

Systems Heterogeneity: an Integrative Way to Understand Cancer Heterogeneity.